Report: Parexel layoffs include up to 200 ex-GlaxoSmithKline staffers

John Carroll

When GlaxoSmithKline reported last December that it was ripping into its R&D operations in Research Triangle Park, NC, and laying off 900 staffers, the pharma giant softened the blow by noting that some 450 of the workers would be transferring to , a major CRO with close ties to Glaxo. But today many of those jobs appear to be in danger after all.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS